Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Flanagan

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 1996
A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNAJ G Lewis, K Y Lin, A Kothavale, et al.
Current Oncology (Toronto, Ont.)|March 18, 2016
Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in CanadaC Popadiuk, C L Gauvreau, M Bhavsar, et al.
Current Oncology (Toronto, Ont.)|December 23, 2017
The OncoSim model: development and use for better decision-making in Canadian cancer controlC L Gauvreau, N R Fitzgerald, S Memon, et al.
Osteoarthritis and Cartilage|November 3, 2009
Development of a population-based microsimulation model of osteoarthritis in CanadaJ A Kopec, E C Sayre, W M Flanagan, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 1996
A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNAJ G Lewis, K Y Lin, A Kothavale, et al.
Current Oncology (Toronto, Ont.)|March 18, 2016
Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in CanadaC Popadiuk, C L Gauvreau, M Bhavsar, et al.
Current Oncology (Toronto, Ont.)|December 23, 2017
The OncoSim model: development and use for better decision-making in Canadian cancer controlC L Gauvreau, N R Fitzgerald, S Memon, et al.
Osteoarthritis and Cartilage|November 3, 2009
Development of a population-based microsimulation model of osteoarthritis in CanadaJ A Kopec, E C Sayre, W M Flanagan, et al.
Pageof 4